March 24, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical”), a commercial-stage pharmaceutical company that primarily focuses on selling and marketing U.S ...
Us Weekly on MSN11d
James Van Der Beek's Most Honest Quotes About His Cancer JourneyJames Van Der Beek has been candid about his health ups and downs since announcing he was diagnosed with colorectal cancer in ...
Journey Medical Corporation (DERM) came out with quarterly earnings of $0.08 per share, beating the Zacks Consensus Estimate of a loss of $0.22 per share. This compares to loss of $0.12 per share ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback